2FD-25042-50618
3 vaccinations
6 coded responses
38 check-ins
6 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 906 / CA
- Registered
- 2020-12-26
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-26
Registered in v-safe
-
2020-12-26
Dose 1 — Pfizer-BioNTech
-
2020-12-27
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Joint pains, Muscle or body achesAdult check-in
- 2020-12-28
- 2020-12-29
- 2020-12-30
- 2020-12-31
- 2021-01-01
- 2021-01-02
-
2021-01-09
Survey response — day 14, dose 1MedDRA: Headache — Feeling: Good · Be unable to workFree text: Headache but I think it was dehydrationMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-09
-
2021-01-16
Dose 2 — Pfizer-BioNTech
-
2021-01-16
Survey response — day 0, dose 2MedDRA: Dizziness — Feeling: Good · Site: Pain · Chills, HeadacheFree text: DizzyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-17
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-18
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-19
- 2021-01-20
- 2021-01-21
- 2021-01-22
- 2021-01-23
- 2021-01-30
-
2021-02-06
Survey response — day 21, dose 2MedDRA: Fatigue — Feeling: FairFree text: FatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-13
- 2021-02-20
- 2021-02-27
- 2021-04-17
- 2021-07-17
-
2021-09-27
Dose 3 — Pfizer-BioNTech
-
2021-09-28
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-09-29
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-09-30
- 2021-10-01
-
2021-10-02
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-10-03
- 2021-10-04
- 2021-10-11
- 2021-10-20
- 2021-10-25
- 2021-11-01
-
2021-11-08
Survey response — day 42, dose 3MedDRA: Headache, Malaise, Pain, SARS-CoV-2 test — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Headache, body ache due to 2nd dose shingrix vaccine. Symptoms resemble Covid-19 so had to get tested to return to workMedDRA releases: 2024-11 · check-in free text available
-
2021-11-08
Report sent to call center — day 42, dose 3Be unable to work or attend school · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2021-11-09
-
2021-12-28
Survey response — 3 months, dose 3MedDRA: Sleep apnoea syndrome — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Newly dx with sleep apneaMedDRA releases: 2024-11 · check-in free text available
-
2021-12-28
Report sent to call center — 3 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-01-04
- 2022-03-28
-
2022-09-27
Survey response — 12 months, dose 3MedDRA: Dyspnoea exertional — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Shortness of breath with exertionMedDRA releases: 2024-11 · check-in free text available
-
2022-09-27
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-09-28
- 2022-09-28
- 2022-09-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-26 | Pfizer-BioNTech | |
| 2 | 2021-01-16 | Pfizer-BioNTech | |
| 3 | 2021-09-27 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-09 | priority 2/3 | |
| 2021-11-08 | Unsuccessful | |
| 2021-12-28 | Unsuccessful | |
| 2022-09-27 | Unsuccessful |
Free text
Release 1 — day 14, dose 1
Symptoms: Headache but I think it was dehydration
Release 2 — day 0, dose 2
Systemic reaction (other): Dizzy
Release 3 — day 21, dose 2
Symptoms: Fatigue
Release 10 — day 42, dose 3
Symptoms: Headache, body ache due to 2nd dose shingrix vaccine. Symptoms resemble Covid-19 so had to get tested to return to work
Release 10 — 3 months, dose 3
Symptoms: Newly dx with sleep apnea
Release 12 — 12 months, dose 3
Symptoms: Shortness of breath with exertion
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dehydration | ○ | ○ | ○ |
| SD | Dyspnoea exertional | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | SARS-CoV-2 test | · | · | ✓ |
| SD | Sleep apnoea syndrome | · | · | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release